Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Live SK08 Powder in IBS-D
NCT06247046Phase 3Recruiting
- Sponsor
- Zhiyi Pharmaceutics
- Start
- Mar 2024
- Primary completion
- Apr 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of SK08 in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Zhiyi Pharmaceutics. Started Mar 2024; status: recruiting.
02
Drugs
SK08
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT06247046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06247046.